These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 31016513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.
    Lew JL, Fenderson JL, Carmichael MG.
    Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009
    [Abstract] [Full Text] [Related]

  • 3. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
    Cha CH, Park CJ, Chi HS, Seo EJ, Jang S, Cho YU, Lee KH, Lee JH, Lee JH, Im HJ, Seo JJ.
    Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
    [Abstract] [Full Text] [Related]

  • 4. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    Barrett J, Saunthararajah Y, Molldrem J.
    Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
    [Abstract] [Full Text] [Related]

  • 5. Clonal evolution in aplastic anemia.
    Afable MG, Tiu RV, Maciejewski JP.
    Hematology Am Soc Hematol Educ Program; 2011 Jan; 2011():90-5. PubMed ID: 22160018
    [Abstract] [Full Text] [Related]

  • 6. [Chronologic analysis of clonal evolution in acquired aplastic anemia and sMDS].
    Yoshizato T.
    Rinsho Ketsueki; 2016 Apr; 57(4):430-9. PubMed ID: 27169446
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
    Paquette RL.
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
    [Abstract] [Full Text] [Related]

  • 11. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
    Durrani J, Maciejewski JP.
    Hematology Am Soc Hematol Educ Program; 2019 Dec 06; 2019(1):97-104. PubMed ID: 31808900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Diagnosis and Therapy of aplastic anemia - update 2021].
    Panse J.
    Dtsch Med Wochenschr; 2021 Apr 06; 146(7):451-454. PubMed ID: 33780990
    [Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of aplastic anemia and lower-risk myelodysplastic neoplasms].
    Suzuki T.
    Rinsho Ketsueki; 2024 Apr 06; 65(9):884-891. PubMed ID: 39358287
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Matsui WH, Brodsky RA, Smith BD, Borowitz MJ, Jones RJ.
    Leukemia; 2006 Mar 06; 20(3):458-62. PubMed ID: 16437138
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clonal hematopoiesis in acquired aplastic anemia.
    Ogawa S.
    Blood; 2016 Jul 21; 128(3):337-47. PubMed ID: 27121470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.